.

Flexible Flat-Rate Plans

Flat-rate pricing for predictable budgeting

Short-term plans for project- or client-based billing

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

ACCOLATE Drug Profile

« Back to Dashboard
Accolate is a drug marketed by Par Pharm Inc and is included in one NDA. It is available from three suppliers.

The generic ingredient in ACCOLATE is zafirlukast. There are two drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the zafirlukast profile page.

Summary for Tradename: ACCOLATE

Patents:0
Applicants:1
NDAs:1
Suppliers / Packagers: see list3

Pharmacology for Tradename: ACCOLATE

Clinical Trials for: ACCOLATE

Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Par Pharm Inc
ACCOLATE
zafirlukast
TABLET;ORAL020547-003Sep 17, 1999RXNo<disabled><disabled>
Par Pharm Inc
ACCOLATE
zafirlukast
TABLET;ORAL020547-001Sep 26, 1996RXYes<disabled><disabled>
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: ACCOLATE

These historical archives are available as an add-on to one-year subscriptions.
See the Signup Form for more information.

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Par Pharm Inc
ACCOLATE
zafirlukast
TABLET;ORAL020547-001Sep 26, 19965,482,963<disabled>
Par Pharm Inc
ACCOLATE
zafirlukast
TABLET;ORAL020547-001Sep 26, 19964,859,692<disabled>
Par Pharm Inc
ACCOLATE
zafirlukast
TABLET;ORAL020547-001Sep 26, 19965,294,636<disabled>
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Paragraph IV activity for: ACCOLATE

Drugname Dosage Strength RLD Submissiondate
zafirlukastTablets10 mg and 20 mgAccolate2/29/2008
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

How are People Using DrugPatentWatch?

`abc